Selected research
Market Structure
Global Cholesterol-Lowering Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cholesterol-Lowering Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cholesterol-Lowering Supplements include Vitabiotics, TCI Co. Ltd., Streamline Pharma Pvt. Ltd., Step One Foods, Solgar, Pure Encapsulations LLC, ORGANIC INDIA Pvt. Ltd., Inlife Pharma Private Limite and Holland & Barrett, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cholesterol-Lowering Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cholesterol-Lowering Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cholesterol-Lowering Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cholesterol-Lowering Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Cholesterol-Lowering Supplements Segment by Company
Vitabiotics
TCI Co. Ltd.
Streamline Pharma Pvt. Ltd.
Step One Foods
Solgar
Pure Encapsulations LLC
ORGANIC INDIA Pvt. Ltd.
Inlife Pharma Private Limite
Holland & Barrett
Himalaya Wellness Company.
HERBAL CREATIONS
Croda International Plc
Cargill
Bioglan
ADM
Cholesterol-Lowering Supplements Segment by Type
Animal-Based
Plant-Based
Others
Cholesterol-Lowering Supplements Segment by Application
Online Sales
Offline Sales
Cholesterol-Lowering Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol-Lowering Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cholesterol-Lowering Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol-Lowering Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cholesterol-Lowering Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cholesterol-Lowering Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cholesterol-Lowering Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cholesterol-Lowering Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Animal-Based
- Plant-Based
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- Vitabiotics
- TCI Co. Ltd.
- Streamline Pharma Pvt. Ltd.
- Step One Foods
- Solgar
- Pure Encapsulations LLC
- ORGANIC INDIA Pvt. Ltd.
- Inlife Pharma Private Limite
- Holland & Barrett
- Himalaya Wellness Company.
- HERBAL CREATIONS
- Croda International Plc
- Cargill
- Bioglan
- ADM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cholesterol-Lowering Supplements Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cholesterol-Lowering Supplements Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cholesterol-Lowering Supplements Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cholesterol-Lowering Supplements Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cholesterol-Lowering Supplements Market Dynamics
- 2.1 Cholesterol-Lowering Supplements Industry Trends
- 2.2 Cholesterol-Lowering Supplements Industry Drivers
- 2.3 Cholesterol-Lowering Supplements Industry Opportunities and Challenges
- 2.4 Cholesterol-Lowering Supplements Industry Restraints
3 Cholesterol-Lowering Supplements Market by Manufacturers
- 3.1 Global Cholesterol-Lowering Supplements Revenue by Manufacturers (2021-2026)
- 3.2 Global Cholesterol-Lowering Supplements Sales by Manufacturers (2021-2026)
- 3.3 Global Cholesterol-Lowering Supplements Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cholesterol-Lowering Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cholesterol-Lowering Supplements Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cholesterol-Lowering Supplements Manufacturers, Product Type & Application
- 3.7 Global Cholesterol-Lowering Supplements Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cholesterol-Lowering Supplements Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cholesterol-Lowering Supplements Players Market Share by Revenue in 2025
- 3.8.3 2025 Cholesterol-Lowering Supplements Tier 1, Tier 2, and Tier 3
4 Cholesterol-Lowering Supplements Market by Type
- 4.1 Cholesterol-Lowering Supplements Type Introduction
- 4.1.1 Animal-Based
- 4.1.2 Plant-Based
- 4.1.3 Others
- 4.2 Global Cholesterol-Lowering Supplements Sales by Type
- 4.2.1 Global Cholesterol-Lowering Supplements Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cholesterol-Lowering Supplements Sales by Type (2021-2032)
- 4.2.3 Global Cholesterol-Lowering Supplements Sales Market Share by Type (2021-2032)
- 4.3 Global Cholesterol-Lowering Supplements Revenue by Type
- 4.3.1 Global Cholesterol-Lowering Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cholesterol-Lowering Supplements Revenue by Type (2021-2032)
- 4.3.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2021-2032)
5 Cholesterol-Lowering Supplements Market by Application
- 5.1 Cholesterol-Lowering Supplements Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Cholesterol-Lowering Supplements Sales by Application
- 5.2.1 Global Cholesterol-Lowering Supplements Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cholesterol-Lowering Supplements Sales by Application (2021-2032)
- 5.2.3 Global Cholesterol-Lowering Supplements Sales Market Share by Application (2021-2032)
- 5.3 Global Cholesterol-Lowering Supplements Revenue by Application
- 5.3.1 Global Cholesterol-Lowering Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cholesterol-Lowering Supplements Revenue by Application (2021-2032)
- 5.3.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2021-2032)
6 Global Cholesterol-Lowering Supplements Sales by Region
- 6.1 Global Cholesterol-Lowering Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cholesterol-Lowering Supplements Sales by Region (2021-2032)
- 6.2.1 Global Cholesterol-Lowering Supplements Sales by Region (2021-2026)
- 6.2.2 Global Cholesterol-Lowering Supplements Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cholesterol-Lowering Supplements Revenue by Region
- 7.1 Global Cholesterol-Lowering Supplements Revenue by Region
- 7.1.1 Global Cholesterol-Lowering Supplements Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cholesterol-Lowering Supplements Revenue by Region (2021-2026)
- 7.1.3 Global Cholesterol-Lowering Supplements Revenue by Region (2027-2032)
- 7.1.4 Global Cholesterol-Lowering Supplements Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cholesterol-Lowering Supplements Revenue (2021-2032)
- 7.2.2 North America Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cholesterol-Lowering Supplements Revenue (2021-2032)
- 7.3.2 Europe Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cholesterol-Lowering Supplements Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Vitabiotics
- 8.1.1 Vitabiotics Company Information
- 8.1.2 Vitabiotics Business Overview
- 8.1.3 Vitabiotics Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Vitabiotics Cholesterol-Lowering Supplements Product Portfolio
- 8.1.5 Vitabiotics Recent Developments
- 8.2 TCI Co. Ltd.
- 8.2.1 TCI Co. Ltd. Company Information
- 8.2.2 TCI Co. Ltd. Business Overview
- 8.2.3 TCI Co. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 8.2.5 TCI Co. Ltd. Recent Developments
- 8.3 Streamline Pharma Pvt. Ltd.
- 8.3.1 Streamline Pharma Pvt. Ltd. Company Information
- 8.3.2 Streamline Pharma Pvt. Ltd. Business Overview
- 8.3.3 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 8.3.5 Streamline Pharma Pvt. Ltd. Recent Developments
- 8.4 Step One Foods
- 8.4.1 Step One Foods Company Information
- 8.4.2 Step One Foods Business Overview
- 8.4.3 Step One Foods Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Step One Foods Cholesterol-Lowering Supplements Product Portfolio
- 8.4.5 Step One Foods Recent Developments
- 8.5 Solgar
- 8.5.1 Solgar Company Information
- 8.5.2 Solgar Business Overview
- 8.5.3 Solgar Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Solgar Cholesterol-Lowering Supplements Product Portfolio
- 8.5.5 Solgar Recent Developments
- 8.6 Pure Encapsulations LLC
- 8.6.1 Pure Encapsulations LLC Company Information
- 8.6.2 Pure Encapsulations LLC Business Overview
- 8.6.3 Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio
- 8.6.5 Pure Encapsulations LLC Recent Developments
- 8.7 ORGANIC INDIA Pvt. Ltd.
- 8.7.1 ORGANIC INDIA Pvt. Ltd. Company Information
- 8.7.2 ORGANIC INDIA Pvt. Ltd. Business Overview
- 8.7.3 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 8.7.5 ORGANIC INDIA Pvt. Ltd. Recent Developments
- 8.8 Inlife Pharma Private Limite
- 8.8.1 Inlife Pharma Private Limite Company Information
- 8.8.2 Inlife Pharma Private Limite Business Overview
- 8.8.3 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio
- 8.8.5 Inlife Pharma Private Limite Recent Developments
- 8.9 Holland & Barrett
- 8.9.1 Holland & Barrett Company Information
- 8.9.2 Holland & Barrett Business Overview
- 8.9.3 Holland & Barrett Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio
- 8.9.5 Holland & Barrett Recent Developments
- 8.10 Himalaya Wellness Company.
- 8.10.1 Himalaya Wellness Company. Company Information
- 8.10.2 Himalaya Wellness Company. Business Overview
- 8.10.3 Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio
- 8.10.5 Himalaya Wellness Company. Recent Developments
- 8.11 HERBAL CREATIONS
- 8.11.1 HERBAL CREATIONS Company Information
- 8.11.2 HERBAL CREATIONS Business Overview
- 8.11.3 HERBAL CREATIONS Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio
- 8.11.5 HERBAL CREATIONS Recent Developments
- 8.12 Croda International Plc
- 8.12.1 Croda International Plc Company Information
- 8.12.2 Croda International Plc Business Overview
- 8.12.3 Croda International Plc Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Croda International Plc Cholesterol-Lowering Supplements Product Portfolio
- 8.12.5 Croda International Plc Recent Developments
- 8.13 Cargill
- 8.13.1 Cargill Company Information
- 8.13.2 Cargill Business Overview
- 8.13.3 Cargill Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Cargill Cholesterol-Lowering Supplements Product Portfolio
- 8.13.5 Cargill Recent Developments
- 8.14 Bioglan
- 8.14.1 Bioglan Company Information
- 8.14.2 Bioglan Business Overview
- 8.14.3 Bioglan Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Bioglan Cholesterol-Lowering Supplements Product Portfolio
- 8.14.5 Bioglan Recent Developments
- 8.15 ADM
- 8.15.1 ADM Company Information
- 8.15.2 ADM Business Overview
- 8.15.3 ADM Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 ADM Cholesterol-Lowering Supplements Product Portfolio
- 8.15.5 ADM Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cholesterol-Lowering Supplements Value Chain Analysis
- 9.1.1 Cholesterol-Lowering Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cholesterol-Lowering Supplements Production Mode & Process
- 9.2 Cholesterol-Lowering Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cholesterol-Lowering Supplements Distributors
- 9.2.3 Cholesterol-Lowering Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst